CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,472 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 90 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and Treasurer gave up 3,000 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,329 shares (to pay taxes)
- 4 Shares withheld for taxes President and COO gave up 4,733 shares (to pay taxes)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes CFO and Treasurer gave up 1,553 shares (to pay taxes)
- 4 Open-market sale President and COO sold 1,455 shares at $19.50 ($28,372)
- 4 Open-market sale Chief Scientific Officer sold 1,373 shares at $19.50 ($26,773)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Executive Officer sold 2,227 shares at $18.26 ($40,663)
- 4 Open-market sale Chief Scientific Officer sold 497 shares at $18.26 ($9,075)
- 4 Shares withheld for taxes CFO and Treasurer gave up 669 shares (to pay taxes)
- 4 Open-market sale President and COO sold 689 shares at $18.26 ($12,581)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
Page 9 of 34 · 670 filings